Gregory KATZ is chaired professor of the ESSEC Chair of Therapeutic Innovation at ESSEC Business School (Paris-Singapore). He is associate professor and co-director of the ESSEC Institute of Health Economics & Management. He holds a Doctorate in pharmacy (Université Paris-Descartes), a Doctorate in philosophy (Université Paris-Sorbonne), and a Master of Business Administration (ESSEC). His teaching activities center on leadership and innovation management in health organizations. His publications focus on the socio-economic impact of biomedical innovation, especially in the field of genomics and stem cell biobanking. As principal investigator, he has published a number of articles in health policy journals such as the Yale J of Public Health, Law and Ethics, and in medical journals such as Transfusion. In 2002, Gregory KATZ published Le Chiffre de la vie : réconcilier la génétique et l’humanisme (Editions du Seuil). He is a member of several journal editorial boards including Philosophy of Management and the International J of Pharmaceutical and Healthcare Marketing. He was a visiting professor at INSEAD (Singapore) in 2004 and at Bocconi University SDA (Itlay) in 2006. He regularly advises public and private organizations in the health sector (hospitals, pharmaceutical firms, health insurance companies and medical device manufacturers). From 2004 to 2009, he was co-founder and elected vice-president of Eurocord, an international platform specialized in clinical research on cord blood stem cell transplantation. For public health issues, he is invited on expert panels by the French Senate, the Conseil d’Etat, the French Health Ministry and the European Parliament. He is an Institutional Review Board member for Paris-Region (CPP-IDF3). Gregory KATZ was the 2008 winner of the San Benedetto Prize awarded by the Fondazione Sublacense for his achievements in bioethics and humanism. Since 2008, he has headed the Fondation Générale de Santé, a non-profit initiative promoting healthcare innovation and humanitarian initiatives through public-private partnerships. In 2009, the Fondation received the Grande Cause Nationale label issued by the French Prime Minister.